McCarter Private Wealth Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.53M Sell
17,679
-375
-2% -$33.3K 0.52% 59
2026
Q2
$1.63M Sell
18,054
-625
-3% -$52.4K 0.56% 53
2026
Q1
$1.5M Sell
18,679
-7,703
-29% -$635K 0.65% 47
2025
Q4
$2.25M Sell
26,382
-15,913
-38% -$1.31M 1.01% 28
2025
Q3
$3.29M Sell
42,295
-752
-2% -$58.8K 1.68% 20
2025
Q2
$3.37M Sell
43,047
-3,903
-8% -$291K 1.93% 14
2025
Q1
$3.4M Sell
46,950
-445
-0.9% -$31.9K 2.23% 17
2024
Q4
$3.51M Buy
47,395
+397
+0.8% +$27.8K 2.23% 14
2024
Q3
$3.1M Buy
+46,998
New +$3.41M 1.96% 16

Other funds holding EW

McCarter Private Wealth Services's EW Position: Q3 2026 in Review

McCarter Private Wealth Services reduced its Edwards Lifesciences (EW) stake by 2.1% in Q3 2026, selling an estimated $33.3K and leaving 17,679 shares worth $1.53M. The position accounts for 0.52% of the portfolio, ranked #59.

McCarter Private Wealth Services first reported a position in EW in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.51M in Q4 2024. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • McCarter Private Wealth Services held 17,679 shares of Edwards Lifesciences worth $1.53M as of Q3 2026.
  • McCarter Private Wealth Services sold 375 Edwards Lifesciences shares in Q3 2026, an estimated $33.3K.
  • Edwards Lifesciences made up 0.52% of McCarter Private Wealth Services's portfolio in Q3 2026, its #59 holding.
  • McCarter Private Wealth Services first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 9 quarters since.
  • McCarter Private Wealth Services's Edwards Lifesciences position peaked at $3.51M in Q4 2024.
  • 326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on McCarter Private Wealth Services's 13F filing for Q3 2026, filed 22 Oct 2026.